Found 50 resultsAuthor [ Title] Type Year
Filters: Author is Lindblad, R [Clear All Filters]
Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials, 39, 211-223. presented at the 11/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25179587. (2014).
Applicability of NINDS-Sponsored Studies to Community-Based Physician Involvement. Neurology, 70, 1688-1690. presented at the 05/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18057316. (2008).
Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial. JAMA Intern Med, 174, 1736-1745. presented at the 09/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25179753. (2014).
CD34+ Cell Selection Using Small Volume Marrow Aspirates: A Platform for Novel Cell Therapies and Regenerative Medicine. Cytotherapy, 12, 170-177. presented at the 04/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20078385. (2010).
Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency. In 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation. presented at the 04/06/2012, New Haven, CT. Retrieved from http://ycci.yale.edu/news/crm2012.aspx. (2012).
Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. Contemp Clin Trials, 34, 196-204. presented at the 03/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23159524. (2013).
Common Data Elements for Substance Use Disorders in Electronic Health Records: The NIDA Clinical Trials Network Experience. Addiction, 108, 3-8. presented at the 01/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22563741. (2013).
Consortium of Food Allergy Research (CoFAR). Relationship of Cytokine and regulatory Gene Expression to the Outcomes of Milk and Egg Allergy in an Atopic Cohort. In AAAAI - American Academy of Allergy, Asthma & Immunology (Vol. 125, p. AB25). presented at the 01/04/2012, Orlando, FL: Journal of Allergy and Clinical Immunology Vol. 129, Issue 2, Supplement, Page AB25. Retrieved from http://download.journals.elsevierhealth.com/pdfs/journals/0091-6749/PIIS0091674911029174.pdf. (2012).
Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals. Contemp Clin Trials, 33, 197-205. presented at the 01/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22005174. (2012).
Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED). Am J Drug Alcohol Abuse, 37, 417-425. presented at the 09/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21854285. (2011).
The Development of a Clinical Decision Support for Illicit Substance Use in Primary Care. In 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA). presented at the 09/21-23/2011, Boston, MA. Retrieved from http://www.bumc.bu.edu/care/education-and-training-programs/inebria/. (2011).
Egg Oral Immunotherapy (OIT) Induces Clinical Desensitization in a Double-Blind, Placebo-Controlled (DBPC) Trial in Egg Allergic Children from the Consortium of Food Allergy Research (CoFAR). In Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. presented at the 2010, New Orleans.. (2010).
Electronic Medical Records (EMR) and Addiction Medicine Care Delivery: NIDA’s Effort in Facilitating the Development and Implementation of EMR. In American Academy of Addiction Psychiatry (AAAP). presented at the 12/08-11/2011, Scottsdale, AZ. Retrieved from http://www.aaap.org/meetings-and-events/past-events/2011-general-information. (2011).
Electronic Medical Records Workshop. In NIDA Clinical Trials Network (CTN) “Electronic Medical Records Workshop”. presented at the 08/05/2011, Rockville, MD.. (2011).
Estimating Death Rates In Substance Use Disorder. In The Society for Clinical Trials 33rd Annual Meeting. presented at the 20/05/2012, Miami, FL. Retrieved from http://www.sctweb.org/public/meetings/2012/home.cfm. (2012).
Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World. Contemp Clin Trials, 33, 993-1002. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22613054. (2012).
Genome-Wide Association Analysis of Eosinophilic Esophagitis Provides Insight Into the Tissue Specificity of This Allergic Disease. Nat Genet, 46, 895-900. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25017104. (2014).
Identifying Core Behavioral and Psychosocial Data Elements for the Electronic Health Record. In Workshop Presentation at the National Institutes of Health (NIH) and Society of Behavioral Medicine (SBM). presented at the 05/02/2011, Bethesda, MD.. (2011).
IgE Sensitization to Milk and Peanut are Associated with Increased IL-4 but not GATA-3 Expression from Antigen-Stimulated Leukocytes in Atopic Infants (COFAR Observational Study of Food Allergy). In Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. presented at the 2010, New Orleans.. (2010).
Immunologic Features of Infants with Milk or Egg Allergy Enrolled in an Observational Study (Consortium of Food Allergy Research) of Food Allergy. J Allergy Clin Immunol, 125, 1077-1083 e1078. presented at the 05/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20451041. (2010).
Implication of Adopting Standardized Common Data Elements in Health IT Systems of Drug-Abuse Treatment Providers. In NIDA CCTN Presentation and Webcast to NIDA on EHR Project. presented at the 05/01/2011, Rockville, MD.. (2011).
Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids. Am J Transplant, 8, 984-989. presented at the 05/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18416737. (2008).
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant, 8(5), 984-9. presented at the 2008 May. doi:10.1111/j.1600-6143.2008.02167.x. (2008).